Page 552 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

540 FLUID THERAPY

44. Forrester JS, Diamond G, Chatterjee K, et al. Medical 63. Hall JE, Guyton AC, Jackson TE, et al. Control of glomer-
therapy of acute myocardial infarction by application ular filtration rate by the renin-angiotensin system. Am J
of hemodynamic subsets. N Engl J Med Physiol 1977;233:F366–F372.
1976;295:1404–13. 64. Hamlin RL, Smith RC, Powere TE, et al. Efficacy of vari-
45. Franciosa JA, Dunkman WB, Wilen M, et al. Optimal” left ous diuretics in normal dogs. J Am Vet Med Assoc
ventricular filling pressure during nitroprusside infusion 1965;146:1417–20.
for congestive heart failure. Am J Med 1983;74:457–64. 65. Heinemann HO. Right-sided heart failure and the use of
46. Francis GS, McDonald KM. Neurohumoral mechanisms diuretics. Am J Med 1978;64:367–9.
in heart failure. In: McCall D, Rahimtoola SH, editors. 66. Higgins CB, Vatner SF, Eckberg DL, et al. Alterations in
Heart failure. New York: Chapman & Hall; 1995. the baroreceptor reflex in conscious dogs with heart fail-
p. 90–116. ure. J Clin Invest 1972;51715–24.
47. Francis GS, Goldsmith SR, Levine TB, et al. The neurohu- 67. Hirsch AT, Muellerleile M, Dzau VJ. Cardiovascular tissue
moral axis in congestive heart failure. Ann Intern Med angiotensin systems: activation and actions in heart failure.
1984;101:370–7. In: McCall D, Rahimtoola SH, editors. Heart failure.
48. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vaso- New York: Chapman & Hall; 1995. p. 117–34.
constrictor response to intravenous furosemide in patients 68. Hirsch AT, Pinto YM, Schunkert H, et al. Potential role of
with chronic congestive heart failure. Activation of the the tissue renin-angiotensin system in the pathophysiol-
neurohumoral axis. Ann Intern Med 1985;103:1–6. ogy of congestive heart failure. Am J Cardiol
49. Francis GS. Neurohumoral mechanisms involved in 1990;66:22D–32D.
congestive heart failure. Am J Cardiol 1985;55:15A–21A. 69. Hollander W, Judson WE. The relationship of cardiovas-
50. Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional cular and renal hemodynamic function to sodium excre-
alterations and the effect of fish oil supplementation in tion in patients with severe heart disease but without
dogs with heart failure. J Vet Intern Med 1998;12:440–8. edema. J Clin Invest 1956;35:970–9.
51. Freeman RH, Davis JD, Williams GM, et al. Effects of the 70. Hollenberg NK. Diuretics in congestive heart failure.
oral angiotensin converting enzyme inhibitor, SQ 14225 In: Messerli FN, editor. Cardiovascular drug therapy.
in a model of low cardiac output in dogs. Circ Res 2nd ed Philadelphia: WB Saunders; 1990. p. 383–8.
1979;45:540–5. 70a. Ichikawa I, pfeffer JM, pfeffer MA, et al. Role of
52. Friedman E, Shadel M, Halkin H, et al. Thiazide-induced Angiotensin II in the altered renal function of congestive
hyponatremia. Ann Intern Med 1989;110:24–30. heart failure, Circ Res. 55:669–75, 1984.
53. Fulop M, Horowitz M, Aberman A, et al. Lactic acidosis in 71. IMPROVE Study Group . Acute and short-term hemody-
pulmonary edema due to left ventricular failure. Ann namic, echocardiographic, and clinical effects of enalapril
Intern Med 1973;79:180–6. maleate in dogs with naturally acquired heart failure:
54. Gaasch WH, Freeman GL. Functional properties of nor- results of the invasive multicenter prospective veterinary
mal and failing hearts. In: McCall D, Rahimtoola SH, evaluation of enalapril study. J Vet Intern Med
editors. Heart failure. New York: Chapman & Hall; 1995;9:234–42.
1995. p. 14–29. 72. Jackson EK. Diuretics. In: Hardman JG, Limbird LE,
55. Gerlag PGG, van Meijel JJM. High-dose furosemide in Molinoff PB, et al., Goodman & Gilman’s the pharmaco-
the treatment of refractory congestive heart failure. Arch logical basis of therapeutics. 9th ed New York: McGraw-
Intern Med 1988;148:286–91. Hill; 1996. p. 685–714.
56. Gottlieb SS, Weir MR. Renal effects of angiotensin- 73. Jensen KT, Carstens J, Pedersen EB. Effect of BNP on
converting enzyme inhibition in congestive heart failure. renal hemodynamics, tubular function and vasoactive
Am J Cardiol 1990;66:14D–21D. hormones in humans. Am J Physiol 1998;274:F63–F72.
57. Gottlieb SS, Abraham W, Butler J, et al. The prognostic 74. Jeunesse E, Woehrle F, Schneider M, Lefebvre HP.
importance of different definitions of worsening renal Effect of spironolactone on diuresis and urine sodium
function in congestive heart failure. J Card Fail and potassium excretion in healthy dogs. J Vet Cardiol
2002;8:136–41. 2007;9(2):63–8.
58. Granger JP. Regulation of sodium excretion by renal inter- 75. Kaloyanides GJ. Pathogenesis and treatment of edema
stitial hydrostatic pressure. Fed Proc 1986;45:2892–6. with special reference to the use of diuretics.
59. Greco DS, Biller B, Van Liew CH. Measurement of plasma In: Maxwell MH, Kleeman CR, editors. Clinical disorders
atrial natriuretic peptide as an indicator of prognosis in of fluid and electrolyte metabolism. New York: McGraw-
dogs with cardiac disease. Can Vet J 2003;44:293–7. Hill; 1980. p. 647–701.
60. Guyton AC, Lindsey AW. Effect of elevated left atrial 76. Katz AM. Cardiomyopathy of overload: a major determi-
pressure and decreased plasma protein concentration on nant of prognosis in congestive heart failure. N Engl J
the development of pulmonary edema. Circ Res Med 1990;322:100–10.
1959;7:649–57. 77. Keane WR, Shapiro BE. Renal protective effects of angio-
61. Haggstrom J, Hansson K, Karlberg BE, et al. Effects of tensin-converting enzyme inhibition. Am J Cardiol
long-term treatment with enalapril or hydralazine on 1990;65:491–531.
the renin-angiotensin-aldosterone system and fluid bal- 78. KeeneBW,RushJE.Therapyofheartfailure.In:EttingerSJ,
ance in dogs with naturally acquired mitral valve regurgi- editor. Textbook of veterinary internal medicine, 3rd ed.
tation. Am J Vet Res 1996;57:1645–52. Philadelphia: WB Saunders; 1989. p. 939–75.
62. Ha ¨ggstro ¨m J, Boswood A, O’Grady M, et al. Effect of 79. Khanna C, Lund EM, Raffe M, et al. Hypomagnesemia in
pimobendan or benazepril hydrochloride on survival 188 dogs: a hospital population-based prevalence study.
times in dogs with congestive heart failure caused by nat- J Vet Intern Med 1998;12:304–9.
urally occurring myxomatous mitral valve disease: the 80. Kim S, Iwao H. Molecular and cellular mechanisms of
QUEST study. J Vet Intern Med 2008;22(5):1124–35. angiotensin II-mediated cardiovascular and renal diseases.
Pharmacol Rev 2001;52:11–34.